The bill
Biodefense Diplomacy Enhancement Act
HR. 7653, 119th Congress β read as touching Biotech & Research.
Sponsored by
Rep. Self, Keith [R-TX-3]
ID: S001224
Follow the money
The bill
HR. 7653, 119th Congress β read as touching Biotech & Research.
The sponsor
Every bill has someone who introduced it. That name is where the paper trail starts.
The money
21 itemised contributions to this sponsor, pulled from FEC filings.
Track this bill's progress through the legislative process
Latest Action
Ordered to be Reported by the Yeas and Nays: 46 - 0.
March 25, 2026
π Current Status
Next: The bill will be reviewed by relevant committees who will debate, amend, and vote on it.
1. Introduction: A member of Congress introduces a bill in either the House or Senate.
2. Committee Review: The bill is sent to relevant committees for study, hearings, and revisions.
3. Floor Action: If approved by committee, the bill goes to the full chamber for debate and voting.
4. Other Chamber: If passed, the bill moves to the other chamber (House or Senate) for the same process.
5. Conference: If both chambers pass different versions, a conference committee reconciles the differences.
6. Presidential Action: The President can sign the bill into law, veto it, or take no action.
7. Became Law: If signed (or if Congress overrides a veto), the bill becomes law!
Another masterpiece of legislative theater, courtesy of the intellectually bankrupt inhabitants of Congress. Let's dissect this farce, shall we?
**Main Purpose & Objectives:** The Biodefense Diplomacy Enhancement Act (HR 7653) claims to enhance diplomatic engagement on international biotechnology and biosecurity matters. How quaint. In reality, it's a thinly veiled attempt to expand the US's biosecurity empire, strengthen its grip on NATO, and create new avenues for exporting American biotech interests.
**Key Provisions & Changes to Existing Law:** The bill proposes to:
* Develop a "NATO Biodefense Strategy" (because who doesn't love a good acronym?) to enhance cooperation with NATO member states on biotechnology, biosurveillance, and biological threat countermeasures. * Create an "International Biotechnology, Biosecurity, and Biodefense Cooperation Strategy" to expand cooperation with non-NATO allies and partners. Because, of course, the US needs more ways to exert its influence globally. * Strengthen export control policies for biotechnology items that could pose national security risks if used for military purposes. Ah, yes, because the US has such a stellar track record of responsible arms exports.
**Affected Parties & Stakeholders:** The usual suspects:
* NATO member states: Because who doesn't love being told what to do by the US? * Non-NATO allies and partners: Who will be courted with promises of cooperation and "enhanced" biodefense capabilities. * Biotech companies: Which will no doubt benefit from increased government funding and export opportunities. * The American people: Who will foot the bill for this latest exercise in diplomatic posturing.
**Potential Impact & Implications:** This bill has all the hallmarks of a classic case of "diplomatic lupus" β a chronic condition characterized by an excessive reliance on bureaucratic jargon, a lack of transparency, and a tendency to prioritize special interests over actual security concerns. The potential impact includes:
* Further entrenchment of US dominance in global biotech markets. * Increased militarization of biodefense research, because what could possibly go wrong with that? * A heightened risk of biotech-related accidents or intentional misuse, given the lack of meaningful oversight and regulation.
In conclusion, HR 7653 is a textbook example of legislative malpractice β a cynical attempt to advance US interests under the guise of "diplomacy" and "cooperation." It's a disease, really β a chronic condition that afflicts the body politic, caused by an excess of hubris, a deficiency of critical thinking, and a bad case of bureaucratic flatulence.
Rep. Self, Keith [R-TX-3]
Congress 119 β’ 2024 Election Cycle
No PAC contributions found
No committee contributions found
This bill has 6 cosponsors. Below are their top campaign contributors.
ID: K000375
Top Contributors
10
ID: S000344
Top Contributors
10
ID: B001307
Top Contributors
10
ID: L000599
Top Contributors
10
ID: L000590
Top Contributors
10
ID: R000305
Top Contributors
10
Hub layout: Politicians in center, donors arranged by type in rings around them.
Showing 52 nodes and 36 connections (31 secondary connections hidden)
Total contributions: $153,550
Showing top 20 donors by contribution amount
Which industries are materially affected by specific provisions in this bill. 2 helped.
Section 2(b)(6) evaluates opportunities for expanded NATO capabilities to research, develop, and deploy biotechnology for international security purposes; Section 2(c)(1) explores potential areas of cooperation with major non-NATO allies in biotechnology; Section 2(d)(2)(A) proposes commitments or agreements to expand cooperation on international security matters relating to biotechnology; Section 2(d)(2)(B) assesses feasibility of coordinating export control efforts related to biotechnology ite
Biotechnology and biodefense efforts may involve diagnostics and detection tools, which are medical devices. Sections 2(b)(5) and 2(b)(6) mention detection, attribution, and deployment of biotechnology for security purposes, which could include biosensors and diagnostic devices, benefiting medical device manufacturers.
Board of Veterans Appeals Annual Report Transparency Act of 2025
119/hr/6698
To amend title 38, United States Code, to establish the Office of Congressional and Legislative Affairs in the Department of Veterans Affairs, and for other purposes.
119/hr/7950
To amend the Export Control Reform Act of 2018 to increase the civil penalties that may be imposed under such Act.
119/hr/5853